Literature DB >> 8201211

Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.

M H Davies1, R F Harrison, E Elias, S G Hübscher.   

Abstract

We report cases of amoxycillin- and flucloxacillin-induced liver damage associated with an acute vanishing bile duct syndrome. Ductopenia was present at the time of first liver biopsy, 3 weeks and 3 months after administration of the two drugs, respectively. Ductopenia apparently occurred as the primary lesion, with no evidence of accompanying portal tract inflammation. Subsequent biopsies showed a persistent paucity of ducts, accompanied by increasing features of chronic cholestasis. Biochemical dysfunction persists at 2 year's follow-up and late prognosis remains guarded.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201211     DOI: 10.1016/s0168-8278(05)80476-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.

Authors:  J P Richardet; A Mallat; E S Zafrani; M Blazquez; J C Bognel; B Campillo
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

2.  Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.

Authors:  Stefan Russmann; James A Kaye; Susan S Jick; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

Review 3.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

Authors:  Herbert L Bonkovsky; David E Kleiner; Jiezhun Gu; Joseph A Odin; Mark W Russo; Victor M Navarro; Robert J Fontana; Marwan S Ghabril; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2017-02-07       Impact factor: 17.425

Review 5.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 6.  Antibacterial-induced hepatotoxicity. Incidence, prevention and management.

Authors:  D K George; D H Crawford
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 7.  Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

Authors:  B M Devereaux; D H Crawford; P Purcell; L W Powell; H P Roeser
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury.

Authors:  V A Maria; R M Victorino
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

9.  Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.

Authors:  Robert J Fontana; Paul H Hayashi; Huiman Barnhart; David E Kleiner; K Rajender Reddy; Naga Chalasani; William M Lee; Andrew Stolz; Thomas Phillips; Jose Serrano; Paul B Watkins
Journal:  Am J Gastroenterol       Date:  2015-09-08       Impact factor: 10.864

10.  Successful liver transplantation for drug-induced vanishing bile duct syndrome.

Authors:  Ahmed Hashim; Ashley Barnabas; Rosa Miquel; Kosh Agarwal
Journal:  BMJ Case Rep       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.